Because the polymorphism rs5030789 in RAD51 and polymorphism rs1799796 in XRCC3 increase the risk of prostate cancer, the correlation of these polymorphisms with age and clinicopathological characteristcs of prostate cancer patients was examined (Table 5). This evidence concerns the gene XRCC3 and Familial prostate cancer.